Literature DB >> 1374448

Persistent productive HIV-1 infection of a CD4- human fetal thymocyte line.

W C Hatch1, K E Tanaka, T Calvelli, W K Rashbaum, Y Kress, W D Lyman.   

Abstract

Human fetal thymuses were obtained from abortuses of HIV-1 seronegative females. Thymocytes were isolated and cultured for 2 days with PHA. Thereafter, the culture was divided and half of the cells were exposed to the HIV-1 RF isolate for 4 h. After this incubation period, the HIV-1 exposed and nonexposed control cells were cultured in RPMI 1640 supplemented with IL-2 for 30 days and subsequently maintained in RPMI without the addition of growth factors. Long term culture of both HIV-1 exposed and control thymocytes has yielded two cell lines that have been maintained for more than 3 yr without the addition of growth factors. Flow cytometry using mAb that recognize T cell differentiation markers was used to analyze cell phenotypes. The HIV-1 exposed thymocyte cell line (E88/RF) was shown to be HIV-1 infected by p24 ELISA, reverse transcriptase activity, immunocytochemistry, in situ hybridization, polymerase chain reaction, electron microscopy, and to produce infectious particles by a syncytial forming assay. The non-HIV-1-exposed thymocyte cell line (T412) has remained negative by all criteria for HIV-1 infection. Flow cytometry showed the T412 cells to be positive for the T cell markers CD45, CD38, and CD4 but negative for all other markers tested. The E88/RF cells are positive for CD45 and CD38 but negative for CD4 and other markers. These data report the isolation of two human fetal thymocyte cell lines; one uninfected and susceptible to HIV-1 infection, and the other persistently and productively infected with HIV-1 with little cytopathology. These findings suggest that HIV-1 can persistently infect early T cells and may alter T cell differentiation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1374448

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  Mechanism of human immunodeficiency virus type 1 localization in CD4-negative thymocytes: differentiation from a CD4-positive precursor allows productive infection.

Authors:  S G Kitchen; C H Uittenbogaart; J A Zack
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  Role for the terminal clasp of HIV-1 gp41 glycoprotein in the initiation of membrane fusion.

Authors:  Chan-Sien Lay; Louise E Ludlow; David Stapleton; Anna K Bellamy-McIntyre; Paul A Ramsland; Heidi E Drummer; Pantelis Poumbourios
Journal:  J Biol Chem       Date:  2011-10-05       Impact factor: 5.157

3.  Host-soluble galectin-1 promotes HIV-1 replication through a direct interaction with glycans of viral gp120 and host CD4.

Authors:  Christian St-Pierre; Hiroshi Manya; Michel Ouellet; Gary F Clark; Tamao Endo; Michel J Tremblay; Sachiko Sato
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

4.  The lipid membrane of HIV-1 stabilizes the viral envelope glycoproteins and modulates their sensitivity to antibody neutralization.

Authors:  Hamid Salimi; Jacklyn Johnson; Manuel G Flores; Michael S Zhang; Yunxia O'Malley; Jon C Houtman; Patrick M Schlievert; Hillel Haim
Journal:  J Biol Chem       Date:  2019-11-22       Impact factor: 5.157

5.  Both neutralization resistance and high infectivity phenotypes are caused by mutations of interacting residues in the human immunodeficiency virus type 1 gp41 leucine zipper and the gp120 receptor- and coreceptor-binding domains.

Authors:  E J Park; G V Quinnan
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

6.  An N-Glycosylated Form of SERINC5 Is Specifically Incorporated into HIV-1 Virions.

Authors:  Shilpi Sharma; Mary K Lewinski; John Guatelli
Journal:  J Virol       Date:  2018-10-29       Impact factor: 5.103

7.  Cell-cell contact viral transfer contributes to HIV infection and persistence in astrocytes.

Authors:  Xiaoyu Luo; Johnny J He
Journal:  J Neurovirol       Date:  2014-12-19       Impact factor: 2.643

8.  Inducible human immunodeficiency virus type 1 packaging cell lines.

Authors:  H Yu; A B Rabson; M Kaul; Y Ron; J P Dougherty
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

9.  Mannose receptor is an HIV restriction factor counteracted by Vpr in macrophages.

Authors:  Jay Lubow; Maria C Virgilio; Madeline Merlino; David R Collins; Michael Mashiba; Brian G Peterson; Zana Lukic; Mark M Painter; Francisco Gomez-Rivera; Valeri Terry; Gretchen Zimmerman; Kathleen L Collins
Journal:  Elife       Date:  2020-03-02       Impact factor: 8.140

10.  Effect of 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine on establishment of human immunodeficiency virus type 1 infection in cultured CD8+ lymphocytes.

Authors:  L Mercure; B J Brenner; D Phaneuf; C Tsoukas; M A Wainberg
Journal:  Antimicrob Agents Chemother       Date:  1994-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.